BEGIN:VCALENDAR
VERSION:1.0
BEGIN:VEVENT
DTSTART:20190925T000000Z
DTEND:20190926T000000Z
LOCATION;ENCODING=QUOTED-PRINTABLE:=0D=0A=0D=0ABelgium
DESCRIPTION;ENCODING=QUOTED-PRINTABLE:2019 ISPE Europe Biotechnology Conference - Visit Allegheny Bradford Corporation in Table 15.=0D=0ABiopharmaceuticals have become a main pillar in the pharmaceutical industry, with significant transformation in the development, strategy, technology and operations. This transformation is a continuous process, which is impacted by other developments in digitalization amongst other factors.=0D=0AEntirely new concepts, such as gene - and cell therapy, are being brought to market, which offers even more possibilities to regenerative medicine or disease remission. However, there are still operational and technological challenges.=0D=0AReproducing large molecules reliably at an industrial scale requires manufacturing capabilities of a previously unknown complexity and sophistication. The starting material that produces recombinant therapeutics are genetically modified living cells that must be frozen for storage, thawed without damage, and made to grow in a reaction vessel. The molecules must then be separated from the cells that cultivated them and the media in which they were produced, all without destroying their complex, fragile structures. This process requires new technologies and capabilities and will be explored at our conference.=0D=0Ahttps://ispe.org/conferences/2019-europe-biotechnology
SUMMARY;ENCODING=QUOTED-PRINTABLE:2019 Europe Biotechnology Conference
PRIORITY:3
END:VEVENT
END:VCALENDAR